Skip to content

Pharmaceutical Care Service in Diabetes

Impact of Pharmaceutical Care Service for Type 2 Diabetes Mellitus Patients in Korea

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02955875
Acronym
IMPACT4-DM
Enrollment
257
Registered
2016-11-04
Start date
2015-01-31
Completion date
2016-06-30
Last updated
2016-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Keywords

Diabetes Mellitus, Type 2, Pharmaceutical Services

Brief summary

The purpose of this study is to examine the effectiveness of pharmaceutical care service in the management of poorly controlled type 2 diabetes mellitus.

Interventions

BEHAVIORALPharmaceutical care

Outpatient drug history management, drug regimen review, patient counseling and education before and/or after physician evaluation on the day of facility visit

Sponsors

Pusan National University Hospital
CollaboratorOTHER
Pusan National University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

Patients who visit Endocrinology and Metabolism department of Pusan National University Hospital, are with type 2 diabetes mellitus, and meet one of the following criteria * Who are diagnosed with type 2 diabetes mellitus for the first time * Who need the education for medication or disease * Who are with poorly controlled blood glucose * Who have poor medication adherence * Who have been hospitalized with diabetes complication or poorly controlled blood glucose * Whose physician recommend the pharmaceutical care to them

Exclusion criteria

Patients who meet one of the following criteria * Who are with gestational diabetes * Who are not able to respond to questionnaires * Who are with severe condition such as cerebrovascular disease, mental disorder, and acquired immune deficiency syndrome * Who are not able to be followed-up during 9 months in Pusan National University Hospital

Design outcomes

Primary

MeasureTime frameDescription
Medications knowledge at 9 months9 monthsPatients' knowledge about diabetes medications was measured by an instrument. The instrument includes items such as the name of medication, mechanism of action, dosage, and side effects.

Secondary

MeasureTime frame
Random blood glucose level at 9 months9 months
Blood pressure at 9 months9 months
Cholesterol level at 9 months9 months
Proportion of participants taking statins 9 months9 months
Proportion of participants managing diabetes complications at 9 months9 months
HbA1c level at 9 months9 months
5-level version of the EQ-5D at 9 months9 months
EQ Visual Analogue Scale at 9 months9 months
Problem Areas In Diabetes-Korean questionnaire at 9 months9 months
Patient Satisfaction Questionnaire-Korean at 9 months9 months
Cost-effectiveness of pharmaceutical care at 9 months9 months
Morisky Medication Adherence Scale at 9 months9 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026